Steven A Stacker Selected Research

Steven A Stacker Research Topics

Disease

42	Neoplasms (Cancer) 01/2023 - 06/2002
19	Neoplasm Metastasis (Metastasis) 01/2017 - 06/2002
15	Lymphatic Metastasis 01/2019 - 08/2004
5	Lymphedema (Milroy Disease) 12/2016 - 11/2002
2	Inflammation (Inflammations) 10/2017 - 02/2005
2	Telangiectasis (Telangiectasia) 03/2014 - 12/2008
2	Hypotrichosis 03/2014 - 12/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2012 - 03/2012
2	Carcinogenesis 01/2010 - 04/2007
2	Carcinoma (Carcinomatosis) 04/2007 - 08/2004
2	Infections 02/2005 - 09/2003
2	Hypoxia (Hypoxemia) 07/2004 - 05/2002
1	Eye Diseases (Eye Disease) 01/2021
1	Animal Disease Models 01/2018
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2018
1	Contact Dermatitis (Eczema, Contact) 10/2017
1	Virus Diseases (Viral Diseases) 10/2017
1	Hyperoxia 01/2016
1	Acute Lung Injury 01/2016
1	Wounds and Injuries (Trauma) 08/2013
1	Vascular Remodeling 10/2011
1	Disease Progression 07/2010
1	Endometrial Neoplasms (Endometrial Cancer) 07/2010
1	Intestinal Polyposis (Polyposis, Intestinal) 01/2010
1	Colorectal Neoplasms (Colorectal Cancer) 09/2008
1	Hemorrhage 04/2007
1	Hyperplasia 08/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2005
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2005
1	Prostatic Neoplasms (Prostate Cancer) 08/2004
1	Margins of Excision 08/2004
1	Extranodal Extension 08/2004
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2004
1	Proteinuria 01/2004
1	Nephrosis 01/2004
1	Atherosclerosis 10/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2003
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 06/2002

Drug/Important Bio-Agent (IBA)

29	Vascular Endothelial Growth Factor DIBA 01/2018 - 06/2002
19	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014 - 05/2002
16	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2002
16	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 05/2002
13	Vascular Endothelial Growth Factor CIBA 01/2023 - 09/2003
11	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 12/2016 - 06/2002
7	Messenger RNA (mRNA)IBA 10/2017 - 05/2002
7	EnzymesIBA 12/2016 - 09/2003
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2013 - 05/2002
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2013 - 05/2002
3	Glycoproteins (Glycoprotein)IBA 12/2016 - 07/2004
3	ProstaglandinsIBA 12/2016 - 02/2012
2	ChemokinesIBA 01/2019 - 01/2008
2	Indicators and Reagents (Reagents)IBA 03/2013 - 09/2005
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2012 - 02/2012
2	beta CateninIBA 01/2010 - 09/2008
2	Transcription Factors (Transcription Factor)IBA 12/2008 - 07/2004
2	Cell Surface ReceptorsIBA 09/2008 - 12/2005
1	MTOR InhibitorsIBA 01/2023
1	ProteomeIBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Chemokine ReceptorsIBA 01/2019
1	CCR10 ReceptorsIBA 01/2019
1	CytokinesIBA 01/2019
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Fibrinolysin FDA Link 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	Chimeric Antigen ReceptorsIBA 01/2016
1	AntibodiesIBA 01/2014
1	Therapeutic UsesIBA 12/2013
1	Bevacizumab (Avastin)FDA Link 06/2013
1	Neutralizing AntibodiesIBA 06/2013
1	Heparin (Liquaemin)FDA LinkGeneric 03/2013
1	Angiogenesis InhibitorsIBA 10/2012
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2012
1	MitogensIBA 08/2011
1	LigandsIBA 09/2008
1	Secreted Frizzled-Related ProteinsIBA 09/2008
1	Monoclonal AntibodiesIBA 01/2008
1	Becaplermin (PDGF-BB)FDA Link 01/2008
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2008
1	Matrix Metalloproteinases (MMPs)IBA 04/2007
1	Keratins (Keratin)IBA 09/2005
1	Hyaluronan ReceptorsIBA 09/2005
1	human FLT4 proteinIBA 09/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2005
1	Vascular Endothelial Growth FactorsIBA 07/2004
1	CreatinineIBA 01/2004
1	SodiumIBA 01/2004
1	Puromycin AminonucleosideIBA 01/2004
1	tyrosine receptor (receptor, tyrosine)IBA 09/2003
1	Phosphotransferases (Kinase)IBA 09/2003
1	Tyrosine Kinase InhibitorsIBA 03/2003
1	Gefitinib (Iressa)FDA Link 03/2003
1	Epidermal Growth Factor (EGF)IBA 03/2003

Therapy/Procedure

14	Therapeutics 01/2023 - 08/2004
2	Immunotherapy 01/2016 - 01/2014
1	Radiotherapy 01/2023
1	Surgical Amputation (Amputations) 10/2003